BRAFV600E mutation in oral melanocytic nevus and oral mucosal melanoma

被引:5
|
作者
de Resende, Taynara Asevedo Campos [1 ]
de Andrade, Bruno Augusto Benevenuto [2 ]
Bernardes, Vanessa Fatima [3 ]
Coura, Bruna Pizziolo [3 ]
Delgado-Azanero, Wilson [4 ]
Mosqueda-Taylor, Adalberto [5 ]
de Almeida, Oslei Paes [6 ]
Gomes, Carolina Cavalieri [3 ]
Gomez, Ricardo Santiago [1 ]
机构
[1] Univ Fed Minas Gerais UFMG, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil
[2] Univ Fed Rio de Janeiro UFRJ, Sch Dent, Dept Oral Diag & Pathol, Rio De Janeiro, Brazil
[3] Univ Fed Minas Gerais UFMG, Biol Sci Inst, Dept Pathol, Belo Horizonte, MG, Brazil
[4] Univ Peruana Ceyetano Heredia, Sch Dent, Dept Oral Pathol Oral Med & Oral Surg, Lima, Peru
[5] Univ Autonoma Metropolitana Xochimilco, Hlth Care Dept, Mexico City, DF, Mexico
[6] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, Brazil
关键词
Oral melanoma; Oral melanocytic nevi; Mucosal melanoma; Oral cancer; BRAF MUTATIONS; NRAS; KIT; GNAQ/GNA11; PROFILE;
D O I
10.1016/j.oraloncology.2020.105053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] OPN3 Regulates Melanogenesis in Human Congenital Melanocytic Nevus Cells through Functional Interaction with BRAFV600E
    Dong, Xian
    Zeng, Wen
    Zhang, Wei
    Lan, Yinghua
    Wang, Yu
    Feng, Jianglong
    Gu, Lingxi
    Lu, Hongguang
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (11) : 3020 - +
  • [32] BrafV600E cooperates with Pten loss to induce metastatic melanoma
    David Dankort
    David P Curley
    Robert A Cartlidge
    Betsy Nelson
    Anthony N Karnezis
    William E Damsky Jr
    Mingjian J You
    Ronald A DePinho
    Martin McMahon
    Marcus Bosenberg
    Nature Genetics, 2009, 41 : 544 - 552
  • [33] Detection of the BRAFV600E mutation in metastatic melanoma by immunohistochemistry: Why it is useful in a daily routine practice?
    Long-Mira, E.
    Ilie, M.
    Lassalle, S.
    Hofman, V.
    Bence, C.
    Butori, C.
    Lalvee, S.
    Lacour, J. -P.
    Bahadoran, P.
    Hofman, P.
    VIRCHOWS ARCHIV, 2014, 465 : S13 - S13
  • [34] Should BRAFV600E Be Tested in Primary or Metastatic Malignant Melanoma?
    Santos-Briz, A.
    Godoy, E.
    Arango, L.
    Antunez, P.
    Alcaraz, E.
    Fernandez, E.
    Ludena, M. D.
    LABORATORY INVESTIGATION, 2013, 93 : 120A - 120A
  • [35] Prognostic Role of BRAFV600E Cellular Localization in Melanoma Discussion
    Tufaro, Anthony
    Chu, Quyen
    Brody, Jonathan
    Kandil, Emad
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 538 - 539
  • [36] Diffuse melanosis cutis in the setting of BRAFV600E metastatic melanoma
    Sebaratnam, Deshan F.
    Martin, Linda K.
    Venugopal, Supriya S.
    Mangos, George
    Freiman, John
    de Souza, Paul
    Farnsworth, Annabelle
    Cheung, Karen
    Scolyer, Richard A.
    Murrell, Dedee F.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (11) : 1409 - 1411
  • [37] Resistance to BRAF and MEK inhibitors in BRAFV600E mutant melanoma
    Patel, Hima
    Mishra, Rosalin
    Joan, Garrett
    CANCER RESEARCH, 2019, 79 (13)
  • [38] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS
    del Bufalo, Francesca
    Cacchione, Antonella
    Carai, Andrea
    Antonelli, Manila
    Giangaspero, Felice
    Ferretti, Elisabetta
    Catanzaro, Giuseppina
    Miele, Evelina
    Badiali, Manuela
    Pettorini, Benedetta
    Mastronuzzi, Angela
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [39] Should BRAFV600E Be Tested in Primary or Metastatic Malignant Melanoma?
    Santos-Briz, A.
    Godoy, E.
    Arango, L.
    Antunez, P.
    Alcaraz, F.
    Fernandez, E.
    Ludena, M. D.
    MODERN PATHOLOGY, 2013, 26 : 120A - 120A
  • [40] BrafV600E cooperates with Pten loss to induce metastatic melanoma
    Dankort, David
    Curley, David P.
    Cartlidge, Robert A.
    Nelson, Betsy
    Karnezis, Anthony N.
    Damsky, William E., Jr.
    You, Mingjian J.
    DePinho, Ronald A.
    McMahon, Martin
    Bosenberg, Marcus
    NATURE GENETICS, 2009, 41 (05) : 544 - 552